Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Xupeng Mu"'
Publikováno v:
Journal of Nanobiotechnology, Vol 21, Iss 1, Pp 1-16 (2023)
Abstract The development of nanotechnology has provided numerous possibilities for the diagnosis and treatment of cancer. Paradoxically, some in vivo experimental studies have also shown that nanoparticles (NPs) could promote tumor progression, but t
Externí odkaz:
https://doaj.org/article/898bd7f753d447e3bdba83de27c06674
Publikováno v:
Cancer Nanotechnology, Vol 14, Iss 1, Pp 1-21 (2023)
Abstract Purpose Owing to the complexity of cancer, a synergistic combination of chemotherapy and gene therapy can be a promising therapeutic strategy. This study aimed to use stem cell membrane (SCM)-camouflaged polydopamine nanoparticles for simult
Externí odkaz:
https://doaj.org/article/50dcf12469e54fa0a565dbd44f19d4a0
Autor:
Hua Yao, Xupeng Mu, Zhenhong Wei, Xiuying Li, Liya Wu, Yongri Jin, Xuwen Li, Jing Li, Jinlan Jiang
Publikováno v:
Cancer Nanotechnology, Vol 13, Iss 1, Pp 1-18 (2022)
Abstract Background Inorganic nanocomposites especially Au nanostructures have exhibited outstanding physicochemical properties in biomedical fields. For further clinical applications on theranostics, especially drug delivery, numerous explorations o
Externí odkaz:
https://doaj.org/article/d1bbfcc747364fcb96078d9a45934fb0
Autor:
Xuejia Hou, Hongyu Jiang, Te Liu, Jun Yan, Fuqiang Zhang, Xiaowen Zhang, Jingtong Zhao, Xupeng Mu, Jinlan Jiang
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 161, Iss , Pp 114455- (2023)
Mesenchymal stem cell-derived exosomes (MSCs-exo) can be used for treating Alzheimer’s disease (AD) by promoting amyloid-β (Aβ) degradation, modulating immune responses, protecting neurology, promoting axonal growth, and improving cognitive impai
Externí odkaz:
https://doaj.org/article/a689cc1e7de44c5790704b0f2f0731f8
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 161, Iss , Pp 114451- (2023)
Nanodrug delivery systems have been widely used in disease treatment. However, weak drug targeting, easy to be cleared by the immune system, and low biocompatibility are great obstacles for drug delivery. As an important part of cell information tran
Externí odkaz:
https://doaj.org/article/61c5d2bf57db45198acbe0fccf89dee3
Autor:
Jiang Zhao, Xiaoqing Wang, Chi Zhang, Mingze He, Ge Bian, Ming Zhang, Mingchuan Liu, Xupeng Mu, Kebang Hu
Publikováno v:
BMC Urology, Vol 22, Iss 1, Pp 1-5 (2022)
Abstract Background Ureteral granulation tissue hemangiomas are rare benign vascular lesions, and they may be clinically asymptomatic or present with massive or recurrent hematuria. Sometimes hemangiomas are difficult to distinguish from malignant ur
Externí odkaz:
https://doaj.org/article/55f767a2e33d43bab2b76ca0f429d6ab
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 158, Iss , Pp 114135- (2023)
Patients with cholangiocarcinoma (CCA) often have an unfavorable prognosis because of its insidious nature, low resectability rate, and poor response to anticancer drugs and radiotherapy, which makes early detection and treatment difficult. At presen
Externí odkaz:
https://doaj.org/article/a308860fdf7946c2947e98cd676d2337
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionOsteosarcoma tumors are the most common malignant bone tumors in children and adolescents. Their treatment usually requires surgical removal of all detectable cancerous tissue and multidrug chemotherapy; however, the prognosis for patient
Externí odkaz:
https://doaj.org/article/7f52c32f18e64c19a13ca39ce56c98a9
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 155, Iss , Pp 113714- (2022)
Prostate cancer (PCa) is the most common new cancer case and the second most fatal malignancy in men. Surgery, endocrine therapy, radiotherapy and chemotherapy are the main clinical treatment options for PCa. However, most prostate cancers can develo
Externí odkaz:
https://doaj.org/article/7c3569088f3a4f048b827c542865ddc4
Autor:
Xuejia Hou, Hongyu Jiang, Te Liu, Jun Yan, Fuqiang Zhang, Xiaowen Zhang, Jingtong Zhao, Xupeng Mu, Jinlan Jiang
Mesenchymal stem cell-derived exosomes (MSCs-exo) can be used for treating Alzheimer’s disease (AD) by promoting amyloid-β (Aβ) degradation, modulating immune responses, protecting neurology, promoting axonal growth, and improving cognitive impai
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::70e178bf063d8fca0d88d14f50723bf9
https://doi.org/10.21203/rs.3.rs-2351885/v1
https://doi.org/10.21203/rs.3.rs-2351885/v1
